With so much on the line in Sunday’s game at Ford Field, the Vikings got creative ahead of their matchup with the Lions. In ...

The Minnesota Vikings have a future QB controversy on their hands and rumors about a JJ McCarthy trade are officially here.

Michael Salfino lays out his reasoning for who the Minnesota Vikings should choose as their QB of the future and who they ...

JPMorgan highlights valuation resets for Viking and Structure Therapeutics, citing opportunities in T2D/obesity and competitive clinical data insights.

“Prediction: The Vikings … trade J.J. McCarthy to the Las Vegas Raiders days before the NFL Draft.” The Vikings could land a haul for McCarthy if they traded him. They sent the No. 11 ...

As the prospect of Darnold staying with the Vikings beyond this season looks more realistic, trade theories have surfaced since ESPN’s Adam Schefter guaranteed that the Vikings will listen to ...

Viking Therapeutics Inc’s profitability metrics reveal financial health. The company currently boasts with a gross margin of -28.11%. The profit margin, also known as the revenue ratio or gross profit ...

In the most recent trading session, Viking Therapeutics, Inc. (VKTX) closed at $40.25, indicating a +1.19% shift from the previous trading day.

Having examined the options trading patterns of Viking Therapeutics, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance ...

Viking Therapeutics(NASDAQ: VKTX) didn't exactly capture investors' hearts in the final month of 2024. The biotech company's share price eroded by 24% in December, primarily on the back of a rival's ...

Viking Therapeutics, Inc. (VKTX) closed the latest trading day at $42.68, indicating a +0.78% change from the previous session's end. This move outpaced the S&P 500's daily loss of 0.04%.